Antiplatelet therapy: Does CYP2C19 genotype affect clinical outcome?

Jurriën M. Ten Berg, Vera H. Deneer

Research output: Contribution to journalReview articlepeer-review

Abstract

Commenting on the results of their meta-analysis, Holmes et al. suggest that CYP2C19 genotype does not affect clinical outcome in patients receiving clopidogrel therapy. However, we do not believe that the data support this conclusion; an association between genotype and outcome remains plausible and could be considered when choosing treatment.

Original languageEnglish
Pages (from-to)192-194
Number of pages3
JournalNature Reviews Cardiology
Volume9
Issue number4
DOIs
Publication statusPublished - 1 Apr 2012

Fingerprint

Dive into the research topics of 'Antiplatelet therapy: Does CYP2C19 genotype affect clinical outcome?'. Together they form a unique fingerprint.

Cite this